Jump to content

Thomas Reh

From Wikipedia, the free encyclopedia

Thomas A. Reh is an American scientist and author.

He received his B.Sc. in biochemistry from the University of Illinois at Urbana-Champaign in 1977 and his Ph.D. in neuroscience from the University of Wisconsin–Madison in 1981. He went on to postdoctoral studies at Princeton University in the lab of Martha Constantine-Paton. He is currently professor of biological structure and former director of the Neurobiology and Behavior Program at the University of Washington.

The overall goal of Reh’s research is to understand the cell and molecular biology of regeneration in the eye.[1] He has worked at the interface between development and regeneration, focusing on the retina. The lab is currently divided into a team that studies retinal development and a team that studies retinal regeneration, with the goal of applying the principles learned from developmental biology to design rationale strategies for promoting retinal regeneration in the adult mammalian retina.

His research has been funded through numerous grants from the National Institutes of Health (NIH) and many private foundations, and he has served on several national and international grant review panels, including NIH study sections, and is currently a member of the Scientific Advisory Board of the Foundation Fighting Blindness and of a start-up biotechnology company, Acucela. He has received several awards for his work, including the AHFMR and Sloan Scholar awards. He has published over 100 journal articles, reviews and books, nearly all in the field of retinal regeneration and development.

Publications

[edit]

Textbooks

[edit]
  • Sanes, Reh, Harris (2005). Development of the Nervous System, 2nd edition. Academic Press; ISBN 0-12-618621-9

References

[edit]
  1. ^ "Thomas A. Reh, PhD". Institute for Stem Cell & Regenerative Medicine. 2021-07-29.
[edit]